LIMINATUS PHARMA, INC. (LIMN) Market Cap
- 2026-09-03: Market Cap $248.49M.
- 2026-08-14: Market Cap $470.12M.
- 2026-06-30: Market Cap $307.84M.
- 2026-05-14: Market Cap $412.87M.
Historical market capitalization from contemporaneous retained split-adjusted close and filed split-adjusted shares outstanding.
- Available history
- 2025-05-30 to 2026-09-03
- Data captured
Historical Market Cap
| Date | Market Cap |
|---|---|
| 2026-09-03 | $248.49M |
| 2026-08-14 | $470.12M |
| 2026-06-30 | $307.84M |
| 2026-05-14 | $412.87M |
| 2026-03-31 | $385.95M |
| 2026-03-27 | $421.85M |
| 2025-12-31 | $825.47M |
| 2025-11-13 | $1.45B |
| 2025-10-03 | $2.34B |
| 2025-09-30 | $2.26B |
| 2025-06-30 | $14.5B |
| 2025-05-30 | $7.06B |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |